Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer
Evasion from apoptosis is a hallmark of cancer. Inhibitor of apoptosis proteins (IAPs) contribute to this hallmark by suppressing the induction of cell death. IAPs were found to be overexpressed in cancerous tissues and to contribute to therapeutic resistance. The present review focuses on the IAP m...
Main Author: | Philipp Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1124600/full |
Similar Items
-
Targeting Inhibitor of Apoptosis Proteins to Overcome Chemotherapy Resistance—A Marriage between Targeted Therapy and Cytotoxic Chemotherapy
by: Tiago Barroso, et al.
Published: (2023-08-01) -
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
by: Laurence Dubrez, et al.
Published: (2013-03-01) -
Differential regulation of inhibitors of apoptosis proteins in Alzheimer’s disease brains
by: Lori-Ann Christie, et al.
Published: (2007-04-01) -
Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer—A Promising Signaling Network for Therapeutic Interventions
by: Ömer Güllülü, et al.
Published: (2021-02-01) -
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
by: Ruqaia Abbas, et al.
Published: (2021-12-01)